Verastem | VSTM - Current Liabilities


Verastem reported $59.71M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Curis USD 19.37M 745K Jun/2025
Cytokinetics USD 202.45M 60.31M Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
Incyte USD 1.52B 176.44M Dec/2025
Laboratory Of America USD 2.82B 194.3M Dec/2025
Novartis USD 27.28B 4.72B Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
Roche Holding CHF 28B 421M Dec/2025
TG Therapeutics USD 153.76M 3.05M Dec/2025
Verastem USD 59.71M 24.09M Sep/2025